News from us and our partners

Tags

Topics

0 results

News
26 June, 2018
NodThera secures £28 million ($40 million) Series A Financing
News
9 June, 2018
Hookipa and Gilead Enter Into A Collaboration And License Agreement To Develop Immunotherapies Against HIV And Hepatitis B
News
1 June, 2018
Zai Lab and Crescendo Biologics Enter Exclusive Worldwide License Agreement for Innovative Protein Therapeutics for Inflammatory Indications
News
22 May, 2018
Sofinnova Partners appoints Dr. Martin T. Rothman as Venture Partner
News
22 May, 2018
Highlife appoints Dr. Martin Rothman as independent member of the board
News
22 May, 2018
Shockwave Launches Coronary Intravascular Lithotripsy in Europe
News
27 April, 2018
Corvidia Therapeutics Secures $60 Million in Series B Funding to accelerate Clinical Work
News
26 April, 2018
Synthace Appoints Bob Wiederhold as Chairman of its Board of Directors
News
24 April, 2018
Sofinnova Partners leads EryDel’s €26.5 million financing
News
23 April, 2018
Armance Bordes joins Sofinnova Partners as General Counsel
News
19 April, 2018
Sofinnova Partners leads Inventiva Pharma €35,5 M capital increase
News
16 April, 2018
Limflow raises €27 million ($33.5 million) in Series C financing led by Sofinnova Partners to advance innovative critical limb ischemia (CLI) treatment
News
11 April, 2018
Biotechnologies : EnobraQ monte en puissance !
News
11 April, 2018
EnobraQ is gaining momentum!
News
4 April, 2018
RefleXion Medical raises $100 million in Series C financing
News
4 April, 2018
Sofinnova Partners launches healthcare Crossover Fund with €275 million ($340 million)

NodThera secures £28 million ($40 million) Series A Financing

Hookipa and Gilead Enter Into A Collaboration And License Agreement To Develop Immunotherapies Against HIV And Hepatitis B

Zai Lab and Crescendo Biologics Enter Exclusive Worldwide License Agreement for Innovative Protein Therapeutics for Inflammatory Indications

Sofinnova Partners appoints Dr. Martin T. Rothman as Venture Partner

Highlife appoints Dr. Martin Rothman as independent member of the board

Shockwave Launches Coronary Intravascular Lithotripsy in Europe

Corvidia Therapeutics Secures $60 Million in Series B Funding to accelerate Clinical Work

Synthace Appoints Bob Wiederhold as Chairman of its Board of Directors

Sofinnova Partners leads EryDel’s €26.5 million financing

Armance Bordes joins Sofinnova Partners as General Counsel

Sofinnova Partners leads Inventiva Pharma €35,5 M capital increase

Limflow raises €27 million ($33.5 million) in Series C financing led by Sofinnova Partners to advance innovative critical limb ischemia (CLI) treatment

Biotechnologies : EnobraQ monte en puissance !

EnobraQ is gaining momentum!

RefleXion Medical raises $100 million in Series C financing

Sofinnova Partners launches healthcare Crossover Fund with €275 million ($340 million)